Method and apparatus for radiation treatment planning
Through the control circuit, the optimized radiation treatment plan is generated, and the penumbra ratio and total penumbra area of the multi-leaf collimator are evaluated, which solves the problems of radiation treatment plan in target distinction and quality assurance, and improves treatment accuracy and quality assurance. Simplifies the planning selection process.
Patent Information
- Application Number
- CN202380030886.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-29
- Filing Date
- 2023-03-23
- Publication Date
- 2024-12-06
AI Technical Summary
Existing radiation disposal plans have difficulty effectively distinguishing the target volume from adjacent tissue when applying energy, resulting in the problem of modeling errors and failure to pass quality assurance.
Generate an optimized radiation disposal plan for adjustable collimation devices through control circuits, automatically generating quality assurance values, including evaluating the movable edge penumbra ratio and total penumbra area of the multi-leaf collimator, providing a user interface to modify and re-revise Optimize the plan to ensure the accuracy of dosage determination.
Improves the accuracy and quality assurance of radiation disposal plans, reduces modeling errors, and allows quick selection of plans that are more likely to pass QA evaluation, helping clinicians choose more effective treatment options.
Smart Images

Figure CN119095647A_ABST
Abstract
Description
Technical Field
[0001] These teachings relate generally to treating a planned target volume of a patient with energy according to an energy-based treatment plan, and more particularly to optimizing the energy-based treatment plan. Background Art
[0002] The use of energy to treat medical conditions comprises a known area of prior art effort. For example, radiation therapy comprises an important component of many treatment plans for reducing or eliminating unwanted tumors. Unfortunately, the energy applied does not inherently distinguish between unwanted material and adjacent tissues, organs, etc. that are desirable or even critical for the continued survival of the patient. As a result, energy such as radiation is typically applied in a carefully administered manner to at least attempt to confine the energy to a given target volume. So-called radiation treatment plans typically function in the above-described manner.
[0003] A radiation treatment plan typically includes specified values for each of the various treatment platform parameters during each of a plurality of sequential fields. A treatment plan for a radiation treatment session is typically generated automatically by a so-called optimization process. As used herein, "optimization" will be understood to refer to improving a candidate treatment plan without necessarily ensuring that the result of the optimization is actually a singular optimal solution. Such optimization typically includes automatically adjusting one or more physical treatment parameters (typically while complying with one or more corresponding constraints on these aspects), and mathematically calculating the possible corresponding treatment outcomes (such as dose levels) to identify a given set of treatment parameters that represents a good compromise between a desired treatment outcome and avoiding undesirable side effects.
[0004] When generating a radiation treatment plan, it can be useful to know that the dose calculation agrees (or is likely to agree) with the actual measurements. Unfortunately, the small multi-leaf collimator aperture specified by a given plan may lead to modeling errors. This in turn may cause the plan quality assurance (QA) to fail the required tolerance criteria. Summary of the invention
[0005] According to a first aspect of the present invention, a method as defined in claim 1 is provided.
[0006] According to a second aspect of the present invention, an apparatus as defined in claim 11 is provided.
[0007] Optional features are defined in the dependent claims. BRIEF DESCRIPTION OF THE DRAWINGS
[0008] The above needs are met, at least in part, by providing a method and apparatus for radiation treatment planning as described in the following detailed description, particularly when studied in conjunction with the accompanying drawings, wherein:
[0009] Figure 1 Includes block diagrams of various embodiments as configured in accordance with these teachings;
[0010] Figure 2 including flow charts as configured in accordance with various embodiments of these teachings;
[0011] Figure 3 including side views of various embodiments as configured in accordance with these teachings;
[0012] Figure 4 including side views of various embodiments as configured in accordance with these teachings;
[0013] Figure 5 Includes side views of various embodiments as configured in accordance with these teachings; and
[0014] Figure 6 Included are diagrams of various embodiments as configured in accordance with these teachings.
[0015] The elements in the drawings are shown for simplicity and clarity, and do not have to be drawn to scale. For example, the size and / or relative positioning of some of the elements in the drawings may be exaggerated relative to other elements to help improve the understanding of the various embodiments of this teaching. In addition, common but well-known elements that are useful or necessary in commercially feasible embodiments are usually not depicted, so as to facilitate the less obstructed viewing of these various embodiments of this teaching. Certain actions and / or steps can be described or depicted in a specific order of occurrence, and those skilled in the art will understand that such specificity about the order is not actually required. The terms and expressions used herein have the common technical meanings of such terms and expressions as given by the technicians of the above-mentioned technical field, unless different specific meanings are set forth in addition herein. Unless otherwise specifically noted, the word "or" should be interpreted as having a disjunctive structure rather than a conjunctive structure when used herein. DETAILED DESCRIPTION
[0016] In general, according to these various embodiments, the control circuit generates an optimized radiation treatment plan for an adjustable collimation device, and then automatically generates at least one quality assurance accuracy value corresponding to the optimized radiation treatment plan. By one approach, the plan includes a plurality of treatment fields. In such a case, automatically generating at least one quality assurance accuracy value may include automatically generating at least in part for each treatment field of at least a substantial number (or all) of those treatment fields.
[0017] By one approach, the quality assurance accuracy value comprises a dimensionless metric. The dimensionless metric may represent, for example, dosimetry accuracy corresponding to an optimized radiation treatment plan.
[0018] By one approach, the foregoing may include calculating the dimensionless metric by evaluating a penumbra ratio corresponding to a movable edge of the adjustable collimator. (For example, when the adjustable collimator comprises a multi-leaf collimator, the movable edge may comprise a leaf edge.) For example, the foregoing may also include calculating a term that at least approximates a total penumbra area for a given control point for a given treatment field in the treatment field (for example, by calculating what portion of the adjustable collimator aperture corresponding to the given control point is within a predetermined penumbra distance from the corresponding movable edge).
[0019] These teachings will be adapted, for example, to present information regarding the aforementioned quality assurance accuracy value via a user interface. By one approach, these teachings will be further adapted to: in response to presenting the information, receiving input from a user via the user interface, modifying the radiation treatment plan based on the input, re-optimizing the radiation treatment plan based on the input, and / or administering therapeutic radiation to a patient using the re-optimized radiation treatment plan.
[0020] So configured, these teachings provide a metric that can be used as a QA accuracy value and can be presented for each treatment field. More specifically, the metric can be used, for example, as a multi-leaf collimator complexity metric to assess the dosimetry accuracy of a given radiation treatment plan. In general, planning can occur faster than taking QA measurements. By providing a useful metric that represents the estimated potential modeling error corresponding to a given plan, a user can, for example, select from among different candidate plans based at least in part on the metric, thereby helping to select a plan that is more likely to pass the QA evaluation.
[0021] These and other benefits may become more apparent upon a thorough review and study of the following detailed description. Referring now to the drawings, and in particular to the Figure 1 , an illustrative device 100 that is compatible with many of these teachings will first be presented.
[0022] In this particular example, enabling device 100 includes control circuit 101. As a "circuit," control circuit 101 thus includes a structure that includes at least one (and typically many) conductive paths (such as paths including conductive metals such as copper or silver) that transmit power in an orderly manner, which path(s) will typically also include corresponding electrical components (including both passive (such as resistors and capacitors) and active (such as any of a variety of semiconductor-based devices) as appropriate) to allow the circuit to implement the control aspects of these teachings.
[0023] Such control circuit 101 may include a fixed-purpose hardwired hardware platform (including but not limited to an application-specific integrated circuit (ASIC) (which is customized by design for a specific purpose rather than an integrated circuit intended for general use), a field programmable gate array (FPGA), etc.), or may include a partially or fully programmable hardware platform (including but not limited to a microcontroller, a microprocessor, etc.). These architectural options for such structures are well known and understood in the art and do not require further description here. The control circuit 101 is configured (e.g., by using corresponding programming as will be familiar to those skilled in the art) to perform one or more of the steps, actions, and / or functions described herein.
[0024] The control circuit 101 is operably coupled to a memory 102. The memory 102 may be integrated into the control circuit 101, or may be physically separate (in whole or in part) from the control circuit 101, as desired. The memory 102 may also be local to the control circuit 101 (where, for example, the two share a common circuit board, chassis, power supply, and / or housing), or may be partially or fully remote to the control circuit 101 (where, for example, the memory 102 is physically located in another facility, city, or even country than the control circuit 101).
[0025] In addition to information as described herein (such as optimization information for a particular patient and information about a particular radiation treatment platform), the memory 102 may also be used, for example, to non-transitorily store computer instructions that, when executed by the control circuit 101, cause the control circuit 101 to behave as described herein. (As used herein, such references to "non-transitory" will be understood to refer to the non-transitory state of the stored content (and thus exclude when the stored content merely constitutes a signal or wave), rather than to the volatility of the storage medium itself, and thus include both non-volatile memory (such as read-only memory (ROM)) and volatile memory (such as dynamic random access memory (DRAM)).
[0026] By an optional approach, the control circuit 101 is also operatively coupled to a user interface 103. The user interface 103 may include any of a variety of user input mechanisms (such as but not limited to a keyboard and keypad, a cursor control device, a touch-sensitive display, a voice recognition interface, a gesture recognition interface, etc.) and / or user output mechanisms (such as but not limited to a visual display, an audio transducer, a printer, etc.) to facilitate receiving information and / or instructions from a user and / or providing information to a user.
[0027] If desired, the control circuit 101 may also be operably coupled to a network interface (not shown). The control circuit 101 configured in this manner may communicate with other elements (both other elements within the device 100 and other elements outside the device 100) via the network interface. Network interfaces, including both wireless and non-wireless platforms, are well known in the art and do not require particular detailed description here.
[0028] By one approach, some or all of any desired patient-related imaging information may be obtained by a computed tomography device 106 and / or other imaging device 107 as is known in the art.
[0029] In this illustrative example, the control circuit 101 is configured to ultimately output an optimized energy-based treatment plan (such as, for example, the optimized radiation treatment plan 113). The energy-based treatment plan typically includes specified values for each of the various treatment platform parameters during each of the plurality of sequential exposure fields. In this case, the energy-based treatment plan is generated by an optimization process, examples of which are further provided herein.
[0030] By one approach, the control circuit 101 can be operably coupled to an energy-based treatment platform 114 that is configured to deliver therapeutic energy 112 to a corresponding patient 104 in accordance with an optimized energy-based treatment plan 113. These teachings are generally applicable for use with any of a wide variety of energy-based treatment platforms / devices. In a typical application setting, the energy-based treatment platform 114 will include an energy source, such as a radiation source 115 of ionizing radiation 116.
[0031] By one approach, the radiation source 115 can be selectively moved via the gantry along an arcuate pathway (where the pathway at least to some extent encompasses the patient itself during the administration of the treatment). The arcuate pathway can include a complete or nearly complete circle as desired. By one approach, the control circuit 101 controls the movement of the radiation source 115 along the arcuate pathway and can accordingly control when the radiation source 115 starts moving, stops moving, speeds up, slows down, and / or the speed at which the radiation source 115 travels along the arcuate pathway.
[0032] As an illustrative example, radiation source 115 may include, for example, a radio frequency (RF) based linear particle accelerator (linac based) x-ray source. A linac is a particle accelerator that greatly increases the kinetic energy of charged subatomic particles or ions by subjecting the charged particles to a series of oscillating electric potentials along a linear beamline, which can be used to produce ionizing radiation (e.g., x-rays) 116 and high energy electrons.
[0033] As desired, a typical energy-based treatment platform 114 may also include: one or more support devices 110 (such as a couch) to support the patient 104 during the treatment session, one or more patient fixation devices 111, a gantry or other movable mechanism that allows selective movement of the radiation source 115, and one or more energy shaping devices (for example, beam shaping devices 117 such as jaws, multi-leaf collimators, etc.) that provide selective energy shaping and / or energy modulation.
[0034] In a typical application setting, it is contemplated herein that the patient support device 110 may be selectively controlled by the control circuit 101 to move in any direction (i.e., any X, Y, or Z direction) during an energy-based treatment session. Because the aforementioned elements and systems are well known in the art, further detailed description of these aspects is not provided herein unless otherwise relevant to the description.
[0035] Reference now Figure 2 , a process 200 that can be performed, for example, in conjunction with the above-described application arrangement (and more specifically via the above-described control circuit 101) will be described. In general, the process 200 is used to facilitate generating an optimized radiation treatment plan 113 to facilitate treating a specific patient with therapeutic radiation using a specific radiation treatment platform according to the optimized radiation treatment plan.
[0036] At block 201, the process 200 provides for generating an optimized radiation treatment plan for an adjustable collimation device. This example contemplates that the plan corresponds to a given patient. Various methods for optimizing radiation treatment plans are known in the art. Since these teachings are not overly sensitive to any particular choice in these aspects, further detailed description of such practice is not provided here for the sake of brevity.
[0037] Various adjustable collimation devices are known in the art, and include adjustable jaws and multi-leaf collimators. As an illustrative example, the following description contemplates that the adjustable collimation device includes a multi-leaf collimator. A multi-leaf collimator includes a plurality of individual portions (referred to as "leaves") formed of a high atomic number material (such as tungsten) that can be independently moved into and out of the path of a radiation therapy beam in order to selectively block (and thereby shape) the beam. Typically, the leaves of a multi-leaf collimator are organized in pairs, the paired leaves are aligned colinearly relative to each other, and the paired leaves can be selectively moved toward and away from each other. A typical multi-leaf collimator has many such leaf pairs, typically more than twenty, fifty, or even one hundred such pairs.
[0038] At block 202 , the process 200 then provides for automatically generating at least one quality assurance accuracy value corresponding to the optimized radiation treatment plan.
[0039] In many application settings, the optimized radiation treatment plan itself will include multiple treatment fields. Each treatment field may include exposing the patient's treatment volume to a radiation beam from a corresponding angle, the radiation beam being at least partially shaped and / or modulated by a given aperture(s) formed by a multi-leaf collimator. In such cases, these teachings may provide for automatically generating a quality assurance accuracy value that directly corresponds to each treatment field in at least a substantial number of the treatment fields (such as at least a majority of the treatment fields, at least ninety percent of the treatment fields, or even all of the treatment fields).
[0040] By one approach, the aforementioned quality assurance accuracy value can include a dimensionless metric representing the accuracy of dosimetry corresponding to the optimized radiation treatment plan. Such a metric can be used, for example, during quality assurance (QA) testing of a radiation treatment platform. QA comprises a known area of prior art effort. For example, see the report entitled "Quality Assurance of Medical Accelerators" by the American Association of Physical Medicine (AAPM) Task Group 142 (TG-142) (2009), which is hereby incorporated herein by this reference.
[0041] By one approach, automatic generation of the metric may include calculating the dimensionless metric at least in part by evaluating a penumbra ratio corresponding to a movable edge (such as a leaf edge) of an adjustable collimator (a multi-leaf collimator in this example).
[0042] Figures 3 to 5 Simple illustrative examples are presented in these regards. Figure 3 A multi-leaf collimator 300 is presented having five leaf pairs (leaf pair 0 indicated by reference numeral 301, leaf pair 1 indicated by reference numeral 302, leaf pair 2 indicated by reference numeral 303, leaf pair 3 indicated by reference numeral 304, and leaf pair 4 indicated by reference numeral 305). The leaves are located at the particular control point CP i At , to form an aperture 306 having a total field opening area (or total aperture area) AT(i). Figure 4 The effective penumbra distances corresponding to the edges of the leaves forming the aperture (including its two side edges and the terminal edge) are illustrated (some of which are indicated by reference numeral 401). Figure 5 The effective penumbra area AP(i) 501 within the aperture 306 at the control point is illustrated.
[0043] By way of example, the foregoing may include calculating a term that at least approximates the total penumbra area for a given control point in a given treatment field. (The degree of approximation may vary as desired, depending on the needs and / or requirements of the application setting. For example, the degree of approximation may be within twenty percent, fifteen percent, ten percent, five percent, one percent, or some other selected degree.) The latter in turn may include calculating what portion of the aperture of an adjustable collimator (such as a multi-leaf collimator in this example) corresponding to a given control point is within a predetermined penumbra distance from a corresponding movable edge (such as a leaf edge of a multi-leaf collimator).
[0044] At optional block 203, if desired, the process 200 will be adapted to present information representing the at least one quality assurance accuracy value described above via the user interface 103 as described above. This may include, for example, presenting the total penumbra ratio value for the treatment plan and for each field separately.
[0045] At optional block 204, the process 200 provides for receiving input from a user via the user interface 103 in response to presenting such information. This may include, for example, receiving user input including new values that may be used to re-optimize the plan. Figure 6 , and by way of example, this may include a user providing input specifying that the maximum penumbra ratio must be less than ninety-one percent.
[0046] By another approach, the user input may include a command to at least attempt to automatically reduce the current penumbra ratio value. In such a case, the optimization algorithm may be configured to automatically generate a target for pushing the achieved penumbra ratio value downward by appending a standard squared cost function term to the achieved penumbra ratio value.
[0047] By yet another approach, the user input may include a maximum limit on the penumbra ratio value (since the larger the penumbra ratio, the higher the risk of failing in plan QA). Such a limit may be applied per field (in which case there may be one limit that applies to all fields, or there may be individual limits that each apply to only one field or to a subset of fields), and / or such a limit may be applied per plan. In some application settings, it may be helpful to know the minimum value that can be achieved. With the above in mind, the total penumbra area may also be normalized so that a value of 0 refers to a fully conformal plan (where the target projection is followed by the collimator, and no leaf modulation is performed, which represents the best plan that can be achieved from a QA perspective). This would then mean that any non-zero penumbra ratio value could be considered to increase complexity and therefore increase the risk of failed QA. This would also mean that any plan could be re-optimized so that the user could request any specified penumbra ratio value [e.g., in the range 0...1].
[0048] At optional block 205 , the process 200 provides for modifying the radiation treatment plan based on the received user input, and then at block 206 , re-optimizing the radiation treatment plan to generate a re-optimized radiation treatment plan.
[0049] At optional block 207 , the re-optimized radiation treatment plan may be used to administer therapeutic radiation to the patient via, for example, the aforementioned radiation treatment platform 114 .
[0050] Additional details will now be provided in conjunction with an illustrative example. It should be understood that the specific details of this example are intended for illustrative purposes and should not be viewed as an example of limitations on the practice of these teachings.
[0051] As noted earlier, radiation treatment plans typically include a collection of fields, each field consisting of a sequence of control points, each of which defines the axis of the treatment machine, the position of a multi-leaf collimator leaf, the collimation position, and / or the level of radiation to be administered. In this example, for each control point, the irradiation opening area corresponding to the leaf position is calculated. This area can be limited by the leaf tip position, or can also include the leaf side faces as desired. (If present, the collimation jaw edges can also be included.)
[0052] A term approximating the total penumbra area AP is calculated by determining how many of the above openings are within the penumbra distance from the leaf tip / side. While the term "penumbra" generally refers to a specific mathematical term describing the scattering of radiation under the leaf edge, in this example, the penumbra distance represents the common penumbra with an approximate combination of errors associated with leaf positioning. In common application settings, typical resulting distances are only a few millimeters, such as 2.8 mm for the leaf tip and 2.3 mm for the leaf side.
[0053] The penumbra ratio (PR) for a given control point (i) can be calculated as
[0054] PR(i)=(AP(i)) / (AT(i)).
[0055] If desired, a normalization method can be used to express PR(i) values in a scale of [0, 1], so that 0 refers to the penumbra area (Ap) which is the minimum value that can be achieved in control point i. If A_c is this minimum value (all leaves / collimation devices are set to the boundaries of the target projection at cp i), then the normalized PR(i) can be calculated as:
[0056]
[0057] This normalized PR can be inserted into the previous equation instead of PR, and then the normalized PR of the entire field will be obtained.
[0058] The actual penumbra metric for a given field is then summed over some (or more typically, all) of the control points in that field. In this example, the foregoing may be weighted by the ratio of monitor units (MU) delivered via each control point. (Monitor units are a known measure of the machine output from a clinical accelerator used for radiation therapy.) In this example, the weight of a control point (i) may be calculated as
[0059] w(i)=0.5*(CMW(i)-CMW(i-1))+0.5*(CMW(+1)-CMW(i))
[0060] Where CMW refers to the cumulative metering weight (where the latter refers to a dimensionless cumulative measurement from 0 to 1 over a sequence of control points in the disposal field and which indicates the amount of radiation that needs to be applied between the control points).
[0061] The dimensionless (i.e., unitless) complexity measure for this field with these control points can then be calculated as
[0062]
[0063] The two sums pass through control point (i) from 1 to N. By one approach, the penumbra distance can be a function of the angle of incidence between the incoming radiation and the tip / side of the leaf. A different penumbra can be used when the collimating jaws define the opening compared to the collimator leaves. Different weightings between the penumbra areas caused by different mechanical beam limiting devices can be employed when appropriate and as needed.
[0064] As the aperture becomes smaller, the total aperture area can become smaller than the penumbra area. Such a situation can result in a quality assurance accuracy value greater than "1". If desired, these teachings can be configured to cap the value at "1". Or, if desired, a result that is actually greater than "1" can be provided as a value.
[0065] Figure 6 A graph 600 is presented which represents the penumbra ratio versus port dosimetry gamma pass-through rate for individual intensity modulated radiation therapy (IMRT) fields. The effective penumbra ratios used to calculate the penumbra ratio in this example are px=2.8mm and py=2.3mm. The gamma criteria are 3% and 1mm, and the threshold is 80%. The graph illustrates that increasing the penumbra ratio in the plan produces a worse gamma pass-through rate between the calculated dose and the measured dose, and after a certain ratio value, the pass-through rate becomes undesirable. This separation value can be used to evaluate the plan and signal the user when the plan should be re-evaluated / re-optimized. Furthermore, the correlation coefficient between the two variables can be considered strong when its absolute value is greater than 0.7. Utilizing Figure 6The correlation between these two variables in is -0.83, which indicates a strong correlation between the penumbra ratio and dosimetry accuracy.
[0066] Compared to other prior art multi-leaf collimator complexity metrics, applicants have determined that the present teachings tend to provide better correlation with measured comparisons. Those skilled in the art will recognize that these teachings produce a dimensionless metric that reflects multi-leaf collimator complexity that avoids the need for special equipment or the need for inappropriate treatment machines and clinician time. The resulting metric can provide a simple way to pre-rank radiation treatment plans and help clinicians decide whether to accept a given generated radiation treatment plan or work to further improve the outcome.
[0067] Those skilled in the art will appreciate that various modifications, changes and combinations may be made to the above-described embodiments without departing from the scope of the present invention, and such modifications, changes and combinations will be deemed to be within the scope of the inventive concept.
Claims
1. A method, include: Through the control circuit: generating an optimized radiation treatment plan for the adjustable collimation device; At least one quality assurance accuracy value corresponding to the optimized radiation treatment plan is automatically generated.
2. The method of claim 1 , wherein the optimized radiation treatment plan comprises a plurality of treatment sites, and wherein at least one quality assurance accuracy value corresponding to the optimized radiation treatment plan is automatically generated. include: At least one quality assurance accuracy value is automatically generated, at least in part, for each of at least a substantial number of the disposal sites.
3. The method of claim 2, wherein at least one quality assurance accuracy value is automatically generated for each of at least a substantial number of the disposal sites. include: At least one quality assurance accuracy value is automatically generated for each of the treatment sites.
4. A method according to any preceding claim, wherein the quality assurance accuracy value comprises a dimensionless measure.
5. The method of claim 4, wherein the dimensionless metric represents a dosimetry accuracy corresponding to the optimized radiation treatment plan.
6. The method of claim 4 or claim 5, wherein the at least one quality assurance accuracy value corresponding to the optimized radiation treatment plan is automatically generated include: The dimensionless metric is calculated at least in part by evaluating a movable edge penumbra ratio corresponding to the adjustable collimator.
7. The method of claim 6, wherein the dimensionless metric is calculated by evaluating a movable edge penumbra ratio corresponding to the adjustable collimator include: A term is calculated, at least in part, that at least approximates a total penumbra area for a given control point for a given treatment field in the treatment field.
8. The method of claim 7, wherein the term that at least approximates the total penumbra area for a given control point in a given treatment field is calculated. include: It is calculated, at least in part, what portion of the adjustable collimator aperture corresponding to the given control point is within a predetermined penumbra distance from the corresponding movable edge.
9. A method according to any preceding claim, further comprising: include: Information representative of the at least one quality assurance accuracy value is presented via a user interface.
10. The method according to claim 9, further comprising: include: receiving input from a user via the user interface in response to presenting the information; modifying the radiation treatment plan based on the input; re-optimizing the radiation treatment plan to generate a re-optimized radiation treatment plan; Therapeutic radiation is administered to the patient using the re-optimized radiation treatment plan.
11. A device, include: A control circuit configured to: generating an optimized radiation treatment plan for the adjustable collimator; At least one quality assurance accuracy value corresponding to the optimized radiation treatment plan is automatically generated.
12. The apparatus of claim 11, wherein the optimized radiation treatment plan comprises a plurality of treatment sites, and wherein the control circuitry is configured to automatically generate at least one quality assurance accuracy value corresponding to the optimized radiation treatment plan at least in part by automatically generating at least one quality assurance accuracy value for each treatment site of at least a substantial number of the treatment sites.
13. The apparatus of claim 12, wherein the control circuit is configured to automatically generate at least one quality assurance accuracy value for each of at least a substantial number of the treatment fields by automatically generating at least one quality assurance accuracy value for each of the treatment fields.
14. The apparatus of any one of claims 11 to 13, wherein the quality assurance accuracy value comprises a dimensionless measure.
15. The apparatus of claim 14, wherein the dimensionless metric represents a dosimetry accuracy corresponding to the optimized radiation treatment plan.
16. The apparatus of claim 14 or claim 15, wherein the control circuit is configured to automatically generate the at least one quality assurance accuracy value corresponding to the optimized radiation treatment plan at least in part by calculating the dimensionless metric by evaluating a movable edge penumbra ratio corresponding to the adjustable collimator.
17. An apparatus according to claim 16, wherein the control circuit is configured to calculate the dimensionless metric by evaluating the movable edge penumbra ratio corresponding to the adjustable collimation device at least in part by calculating a term that at least approximates the total penumbra area for a given control point for a given treatment field in the treatment field.
18. An apparatus according to claim 17, wherein the control circuit is configured to calculate the term that at least approximates the total penumbra area for a given control point in the treatment field at least in part by calculating what portion of the adjustable collimator aperture corresponding to the given control point is within a predetermined penumbra distance from the corresponding movable edge.
19. The apparatus according to any one of claims 11 to 18, wherein the control circuit is further configured to: Information representative of the at least one quality assurance accuracy value is presented via a user interface.
20. The apparatus of claim 19, wherein the control circuit is further configured to: receiving input from a user via the user interface in response to presenting the information; modifying the radiation treatment plan based on the input; re-optimizing the radiation treatment plan to generate a re-optimized radiation treatment plan; Administration of therapeutic radiation to the patient using the re-optimized radiation treatment plan is facilitated.
